News

Clinical Epidemiologist, Mathematician, Open Science & Blockchain Enthusiast Dr. Mehdi Benchoufi Joins Saama Advisory Board

CAMPBELL, CA — (June 18, 2018) – Saama Technologies, Inc., a leading big data and advanced analytics solutions company, today announced that Mehdi Benchoufi, M.D., Assistant Professor in the Clinical Epidemiology Center at Hôtel-Dieu Hospital, University Paris Descartes, has joined its Board of Advisors (BOA). Dr. Benchoufi focuses on interfaces between clinical research and open technologies, with…

Read More

Saama Launches Deep Learning Intelligent Assistant (DaLIA) to Solve Clinical Development Pain Points

AI-Informed Virtual Assistant Elevates Functionality of Existing Clinical Trial Solutions CAMPBELL, CA – (June 11, 2018) – Saama Technologies, Inc., a leading data analytics company, today announced the launch of a unique set of Artificial Intelligence (AI) capabilities specifically designed to alleviate the planning, feasibility and conduct challenges inherent in and pervasive throughout the drug…

Read More

Dr. Ajit Shetty, Innovative Chairman Behind Janssen Pharmaceutical’s Global Transformation, Joins Saama’s Board of Directors

CAMPBELL, CA – (June 4, 2018) – Saama Technologies, Inc., a leading data analytics company, today announced that life sciences industry veteran and respected operational authority Ajit Shetty, Ph.D., has joined the company’s Board of Directors. Dr. Shetty brings significant enterprise-wide supply chain and management experience from over four decades at Fortune 100 pharmaceutical companies,…

Read More

Saama Technologies and ICON Commercialization and Outcomes Partner to Unlock The Value of Real World Evidence (RWE)

ICON’s Late Phase Experts to Leverage Saama’s Award-Winning Life Science Analytics Cloud to Support Improved Commercial Decision Making   CAMPBELL, CA – (May 15, 2018) – Saama Technologies, a leading clinical and health data analytics company, and ICON plc (NASDAQ: ICLR), a global provider of drug development and commercialization solutions and services, have partnered to…

Read More

Elligo Health Research and Saama Technologies Announce Strategic Partnership to Advance Clinical Research Data Management

Austin, Texas, and Campbell, Calif., Feb. 28, 2018 — Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, is partnering with Saama Technologies, Inc., a leading clinical data analytics company, to improve awareness of, access to, and participation in clinical trials…

Read More

Saama Partners with Informa Pharma Intelligence’s Citeline to Bridge Clinical Trial Information to Real World Evidence for Unprecedented Customer Experience

Collaboration Aligns Advanced Analytics Industry Leader with Gold-Standard Trial Registry Innovator CAMPBELL, CA – (February 12, 2018) – Saama Technologies, Inc., a leading clinical analytics company, and Citeline, part of Informa Pharma Intelligence’s suite of pharmaceutical and biomedical research and analysis solutions, unveiled a strategic partnership today that will disrupt and advance the existing clinical…

Read More

Saama’s Life Science Ecosystem Helps Partners Leverage Its Award-Winning Clinical Data Analytics Solutions without Replacing Existing Vendors

CAMPBELL, CA – (February 12, 2018) – Saama Technologies, a leading clinical data analytics company, has launched the Life Science Ecosystem for its partners. The Life Science Ecosystem facilitates complementary and tailored application of its award-winning Life Science Analytics Cloud (LSAC) to customers’ preferred systems and services vendors. The ecosystem further solidifies the company’s commitment…

Read More

Saama Welcomes Internationally-Recognized Life Sciences Expert, Dr. Mak Jawadekar, to Board of Advisors

CAMPBELL, CA – (January 3, 2018) – Saama Technologies, Inc., a leading clinical analytics company, today announced that renowned scientist Makarand (Mak) Jawadekar, Ph.D., accepted a position on the company’s Board of Advisors. Dr. Jawadekar brings over three decades of drug discovery and development experience to his partnership with Saama, including extensive expertise creating and…

Read More

Related Posts